Search research articles
Contact Us
Filters
Showing results (121-130 of 169) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2024
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274
Matthew D Galsky, Johannes Alfred Witjes, Jürgen E Gschwend, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
Min Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Cancer
|
August 9, 2020
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
Victor McPherson, Brendan Reardon, Aravind Bhayankara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2018
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
Gopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Roy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 169) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2024
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274
Matthew D Galsky, Johannes Alfred Witjes, Jürgen E Gschwend, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
Min Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Cancer
|
August 9, 2020
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
Victor McPherson, Brendan Reardon, Aravind Bhayankara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2018
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
Gopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Roy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Page
of 17